Results 71 to 80 of about 53,170 (302)
REEP4 variant analysis in blepharospasm and other neurological disorders
Introduction: In preceding work, a deleterious REEP4 variant [GRCh38/hg38, NC_000008.11:g.22140245G>A, NM_025232.4:c.109C>T, p.Arg37Trp] was found to co-segregate with blepharospasm (BSP) in a large African-American pedigree.
Samira Saeirad +2 more
doaj +1 more source
ABSTRACT Smith–Magenis syndrome (SMS) results from either a recurrent 17p11.2 deletion or pathogenic variants in the retinoic acid induced 1 gene (RAI1). While neurodevelopmental impairment and behavioral dysregulation are well recognized, systematic genotype‐stratified analyses across psychiatric domains remain limited.
Albin Blanc +7 more
wiley +1 more source
ABSTRACT DNM1 encephalopathy is a rare autosomal dominant genetic condition characterized by a range of neurological and developmental manifestations. The typical phenotype is severe, including profound intellectual disability, treatment‐resistant epilepsy, ataxia, and structural brain abnormalities. However, milder presentations have increasingly been
Caroline Crain +6 more
wiley +1 more source
Dystonia has many facets, and among those, this book commences with the increasingly associated genes identified, including a construct on how biology interacts with the dystonia genesis.
core +1 more source
DYSTONIA LENTICULARIS (DYSTONIA MUSCULORUM DEFORMANS)
The condition generally recognized as dystonia musculorum deformans, a name given it by Oppenheim, is of special interest at this time in view of the recent significant researches concerning the functions of the basal ganglia, especially of the nucleus lenticularis.
openaire +1 more source
ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim +12 more
wiley +1 more source
Epidemiology of primary and secondary dystonia [PDF]
During the last decade, dystonia has been increasingly recognized. However, the body of work concerning the epidemiology of this condition is not extensive.
Defazio G, DEFAZIO, Giovanni
core
Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of disorders involving peripheral nerve terminal hyperexcitability.
Hidetaka eKoizumi +11 more
doaj +1 more source
Objective Initially described in 1976, X‐linked dystonia parkinsonism (XDP) is a neurodegenerative disease that can be characterized by the presentation of dystonia and parkinsonism symptoms. Although this disease bears some resemblance to other neurodegenerative diseases in terms of symptomatology, the pathological signature of XDP is still unclear ...
Adelie Y.S. Tan +19 more
wiley +1 more source
Accounting for Dystonia: Personalising Illness Through Narrative [PDF]
This paper explores how people living with dystonia, a chronic neurological condition involving involuntary muscle spasms in multiple body parts, use narrative to make sense of illness by linking past, present and future, and giving their condition ...
Camfield, Laura
core

